Dianthus Therapeutics, Inc. /DE/ Public Float
Dianthus Therapeutics, Inc. /DE/ (DNTH) had Public Float of $599.40 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $599.40M.
- 2024-06-30: Entity Public Float $651.00M.
- 2023-06-30: Entity Public Float $32.10M.
- 2022-06-30: Entity Public Float $56.30; Entity Public Float as first filed $56.30M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $599.40M 10-K · filed 2026-03-09 | |
| 2024-06-30 | $651.00M 10-K · filed 2025-03-11 | |
| 2023-06-30 | $32.10M 10-K · filed 2024-03-21 | |
| 2022-06-30 | $56.30 10-K/A · filed 2023-05-01 | $56.30M 10-K · filed 2023-03-23 |
| 2021-06-30 | $436.00M 10-K · filed 2022-03-08 | |
| 2020-06-30 | $246.40M 10-K · filed 2021-03-03 | |
| 2019-06-28 | $364.10M 10-K · filed 2020-03-03 | |
| 2018-06-29 | $209.10M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |